Published April 27, 2018
| Version v2
Dataset
Open
The process of HDAC11 Assay Development: time-course study follow-up
Description
The time of incubation and conc. of the developer to be used are important parameters during HDAC11 assay optimization and thus, have been considered here.
Version2 (v2) has updated reaction recipe.
Notes
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
27april2018-HDAC11 assay deve process-time course followup.pdf
Files
(312.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:c744051da19144a97749af66307162e2
|
174.5 kB | Preview Download |
|
md5:ecf80ee188df74f69a6156e860049959
|
137.8 kB | Preview Download |